Emerald Advisers, LLC Collegium Pharmaceutical, Inc Transaction History

Emerald Advisers, LLC

$2.41 Billion
Q3 2024

A detailed history of Emerald Advisers, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Emerald Advisers, LLC holds 827,302 shares of COLL stock, worth $24.6 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares

827,302

Previous 650,173 27.24%

Holding current value

$24.6 Million

Previous $20.9 Million 52.69%

% of portfolio

1.33%

Previous 0.94%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$31.4 - $39.07 $5.56 Million - $6.92 Million	177,129 Added 27.24%	827,302 $32 Million
Q2 2024 Aug 06, 2024	SELL	$31.36 - $39.99 $606,471 - $773,366	-19,339 Reduced 2.89%	650,173 $20.9 Million
Q1 2024 May 08, 2024	BUY	$31.23 - $40.91 $106,681 - $139,748	3,416 Added 0.51%	669,512 $26 Million
Q4 2023 Feb 05, 2024	SELL	$21.16 - $30.8 $516,113 - $751,242	-24,391 Reduced 3.53%	666,096 $20.5 Million
Q3 2023 Oct 26, 2023	SELL	$21.23 - $24.28 $2.43 Million - $2.78 Million	-114,303 Reduced 14.2%	690,487 $15.4 Million
Q2 2023 Jul 25, 2023	BUY	$21.06 - $24.0 $34,833 - $39,696	1,654 Added 0.21%	804,790 $17.3 Million
Q1 2023 May 04, 2023	SELL	$23.0 - $29.88 $242,719 - $315,323	-10,553 Reduced 1.3%	803,136 $19.3 Million
Q4 2022 Feb 03, 2023	SELL	$16.14 - $23.55 $55,844 - $81,483	-3,460 Reduced 0.42%	813,689 $18.9 Million
Q3 2022 Oct 25, 2022	BUY	$15.46 - $20.1 $72,213 - $93,887	4,671 Added 0.57%	817,149 $13.1 Million
Q2 2022 Jul 29, 2022	BUY	$14.22 - $20.88 $175,759 - $258,076	12,360 Added 1.54%	812,478 $14.4 Million
Q1 2022 Apr 29, 2022	BUY	$17.2 - $22.5 $3.87 Million - $5.07 Million	225,281 Added 39.19%	800,118 $16.3 Million
Q4 2021 Feb 02, 2022	SELL	$17.5 - $21.35 $269,832 - $329,195	-15,419 Reduced 2.61%	574,837 $10.7 Million
Q3 2021 Oct 28, 2021	SELL	$17.75 - $25.39 $2.68 Million - $3.83 Million	-151,022 Reduced 20.37%	590,256 $11.7 Million
Q2 2021 Jul 29, 2021	SELL	$21.74 - $25.28 $166,528 - $193,644	-7,660 Reduced 1.02%	741,278 $17.5 Million
Q1 2021 Apr 29, 2021	SELL	$19.25 - $26.1 $1.67 Million - $2.26 Million	-86,704 Reduced 10.38%	748,938 $17.8 Million
Q4 2020 Jan 29, 2021	BUY	$17.83 - $22.29 $2.18 Million - $2.73 Million	122,279 Added 17.14%	835,642 $16.7 Million
Q3 2020 Oct 28, 2020	BUY	$15.78 - $20.82 $2.13 Million - $2.81 Million	135,050 Added 23.35%	713,363 $14.9 Million
Q2 2020 Jul 28, 2020	SELL	$15.49 - $23.51 $2.9 Million - $4.41 Million	-187,517 Reduced 24.49%	578,313 $10.1 Million
Q1 2020 Apr 30, 2020	SELL	$13.89 - $25.45 $208,211 - $381,495	-14,990 Reduced 1.92%	765,830 $12.5 Million
Q4 2019 Jan 29, 2020	BUY	$10.7 - $22.24 $8.35 Million - $17.4 Million	780,820 New	780,820 $16.1 Million

Others Institutions Holding COLL

# of Institutions

255

Shares Held

36.9M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.01B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Collegium Pharmaceutical, Inc Transaction History